TC Medical(SH:600763) Sou Hu Cai Jing·2025-11-14 11:51Core Viewpoint - Tongce Medical (600763) experienced a slight decline in stock price, closing at 44.68 yuan on November 14, 2025, with a trading volume of 9.94 million shares and a turnover of 449 million yuan [1] Group 1: Stock Performance and Trading Data - On November 14, 2025, the net outflow of main funds was 11.47 million yuan, accounting for 2.56% of the total turnover, while retail funds saw a net inflow of 25.42 million yuan, representing 5.67% of the total turnover [1] - The stock's performance over the past five days shows fluctuations, with a notable drop on November 13, where the stock price was 44.75 yuan, reflecting a 0.36% increase, but with a significant net outflow of main funds at 38.44 million yuan, which was 12.79% of the total [2] Group 2: Financial Metrics and Industry Comparison - As of the latest report, Tongce Medical's total market value is 19.985 billion yuan, with a net asset of 4.703 billion yuan and a net profit of 514 million yuan, ranking 8th, 12th, and 6th respectively in the medical services industry [3] - The company reported a year-on-year revenue increase of 2.56% for the first three quarters of 2025, totaling 2.29 billion yuan, with a net profit of 514 million yuan, reflecting a 3.16% increase [3] - The gross profit margin stands at 41.69%, significantly higher than the industry average of 35.56%, and the net profit margin is 26.91%, compared to the industry average of 4.43% [3] Group 3: Analyst Ratings and Target Price - In the last 90 days, 11 institutions have rated the stock, with 8 buy ratings and 3 hold ratings, indicating a positive outlook [4] - The average target price set by analysts over the past 90 days is 51.78 yuan, suggesting potential upside from the current trading price [4]